Post-approval studies (Phase 4)Not Yet RecruitingNCT06900166
What this trial is testing
Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg
Who this might be right for
Chronic Hepatitis B
Huashan Hospital 360